Industry Trends | Published:

Functional antigenics

Nature Biotechnology volume 16, pages 305307 (1998) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Pharmaceutical Research Manufacturer's Association (PhRMA), 1997.

  2. 2.

    1997. Nature Biotechnol. 15:1409–1411.

  3. 3.

    Such antigens are mostly peptides, but they can also be glycopeptides, lipopeptides, or other types of nonpeptide molecule.

  4. 4.

    and 1982. Nature 296:359.

  5. 5.

    et al. 1996. Prostate 29:371–380.

  6. 6.

    et al. 1995. J. Immunol. 154:3961–3968.

  7. 7.

    et al. 1995. Nat. Meet. 1:1297–1302.

  8. 8.

    and 1990. Biopolymers 29:1755.

  9. 9.

    et al. 1996. J. Exp. Med. 183:527–534.

  10. 10.

    et al. 1997. Immunity 6:273–281.

  11. 11.

    et al. 1991. Science 254:1643–1647.

  12. 12.

    et al. 1993. Proc. Natl. Acad. Sci. USA 90:10275–10279.

  13. 13.

    et al. 1988. Ann. NY Acad. Sci. 532:280–291.

  14. 14.

    et al. 1997. Anal. Chem. 69:767–776.

  15. 15.

    1996. Immunoheraphy:Current status and markets. Financial Times Management Reports.

Download references

Author information

Affiliations

  1. Aris Persidis is vice president for business development at Argonex Inc., 2044 India Road, Suite 202, Charlottesvilk, VA 22901 (apersidis@ar gonex.com).

    • Aris Persidis

Authors

  1. Search for Aris Persidis in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0398-305

Further reading